Department of Neurosurgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University, No. 5, Fuxing St., Guishan Dist., Taoyuan City 333, Taiwan.
Department of Neurosurgery, Chang Gung Memorial Hospital at Keelung, Chang Gung University, Keelung, Taiwan.
Strahlenther Onkol. 2023 Aug;199(8):718-726. doi: 10.1007/s00066-022-02011-3. Epub 2022 Nov 3.
Initial tumor enlargement (or pseudoprogression) instead of true tumor progression is a common phenomenon in patients with acoustic neuromas who are treated with stereotactic radiosurgery (SRS). This phenomenon can affect clinical decision-making and patient management. This study assessed the correlation between initial tumor enlargement and magnetic resonance imaging characteristics in patients with acoustic neuromas who were treated with linear accelerator (LINAC)-based SRS. The long-term tumor control outcomes were also analyzed.
In total, 330 patients with sporadic acoustic neuromas who were treated with LINAC SRS between March 2006 and March 2020 were retrospectively evaluated to assess their initial tumor enlargement. The tumors were divided into homogeneously enhanced, heterogeneously enhanced, and cystic types based on the morphological characteristics noted on magnetic resonance images. Tumor control was assessed in 275 patients with a follow-up duration of more than 2 years.
Initial enlargement was observed in 137 of 330 (41.5%) tumors as early as 3 months after LINAC SRS. Data analysis revealed that postoperative tumors with a residual volume lower than 2.5 cm had a lower incidence of initial enlargement (p = 0.039). No correlation was noted between the initial enlargement and morphological characteristics of tumors. In patients with a mean follow-up duration of 82.8 ± 37.2 months, heterogeneously enhanced tumors exhibited a lower control rate than homogeneously enhanced and cystic tumors (p = 0.045). No correlation was noted between initial enlargement and tumor control.
Initial enlargement can occur as early as 3 months after SRS. Postoperative residual tumors with a volume lower than 2.5 cm exhibit a lower incidence of initial enlargement. Heterogeneously enhanced tumors have a lower local control rate.
在接受立体定向放射外科(SRS)治疗的听神经瘤患者中,初始肿瘤增大(或假性进展)而不是真正的肿瘤进展是一种常见现象。这种现象会影响临床决策和患者管理。本研究评估了接受基于直线加速器(LINAC)的 SRS 治疗的听神经瘤患者初始肿瘤增大与磁共振成像特征之间的相关性,并分析了长期肿瘤控制结果。
共回顾性评估了 2006 年 3 月至 2020 年 3 月期间接受 LINAC SRS 治疗的 330 例散发性听神经瘤患者,以评估其初始肿瘤增大情况。根据磁共振图像上观察到的形态特征,将肿瘤分为均匀增强、不均匀增强和囊性三种类型。对 275 例随访时间超过 2 年的患者进行肿瘤控制评估。
LINAC SRS 后 3 个月内,330 例肿瘤中有 137 例(41.5%)出现早期增大。数据分析显示,术后残余体积低于 2.5cm 的肿瘤初始增大发生率较低(p=0.039)。肿瘤的初始增大与形态特征之间无相关性。在平均随访 82.8±37.2 个月的患者中,不均匀增强肿瘤的控制率低于均匀增强和囊性肿瘤(p=0.045)。肿瘤的初始增大与肿瘤控制之间无相关性。
SRS 后最早可在 3 个月内发生初始增大。术后残余体积小于 2.5cm 的肿瘤初始增大发生率较低。不均匀增强肿瘤局部控制率较低。